AGILE SCIENCES, INC.

Basic Information

1791 VARSITY DR STE 150
RALEIGH, NC, 27606-0000

Company Profile

n/a

Additional Details

Field Value
DUNS: 828576202
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 3


  1. Development of novel anti-biofilm compounds for treating chronic wounds

    Amount: $635,323.00

    DESCRIPTION provided by applicant Chronic wounds that fail to respond to traditional therapeutic interventions afflict millions of people each year and direct costs associated with treating these ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  2. Small molecules as antibiotic potentiating agents against multi-drug resistant Gram-negative infections

    Amount: $641,088.00

    DESCRIPTION provided by applicant Antibiotic resistance has been declared one of the three greatest threats to human health by the World Health Organization Infections caused by multi drug resista ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  3. Anti-biofilm agents for the treatment of pulmonary infection in cystic fibrosis p

    Amount: $1,499,094.00

    DESCRIPTION provided by applicant The leading cause of mortality in patients with cystic fibrosis CF is pulmonary failure from lung infections and the predominant organism isolated from these in ...

    STTR Phase II 2014 Department of Health and Human Services National Institutes of Health
  4. Evaluation of a new class of molecules for treating MRSA infective endocarditis

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Patients with infective endocarditis (IE) have a poor prognosis with one third of the patients succumbing to the infection within the first year. Treatments for en ...

    STTR Phase I 2013 Department of Health and Human Services
  5. Targeting Oral Biofilms with 2-Aminoimidazole/Triazole Conjugates

    Amount: $1,030,274.00

    DESCRIPTION (provided by applicant): Dental caries is one of the most prevalent diseases in the U.S. with 85% of adults and the majority of children having been treated for at least one incidence. Wh ...

    SBIR Phase II 2012 Department of Health and Human Services
  6. SBIR Phase I: Enhancing the Bactericidal Activity of Copper: An Economically Viable Solution for Lowering Copper Usage Rates in Agriculture

    Amount: $150,000.00

    This Small Business Innovation Research Phase I project describes a cost-effective method for reducing the quantities of copper used for agricultural crop protection. Currently, millions of pounds of ...

    SBIR Phase I 2012 National Science Foundation
  7. Small Molecules to Enhance Bacterial Susceptibility to Antiseptics

    Amount: $257,221.00

    DESCRIPTION (provided by applicant): One-third of costs associated with hospital acquired infections (HAIs) are attributed to surgical site infections (SSIs), and SSIs result in a two-fold increase in ...

    SBIR Phase I 2012 Department of Health and Human Services
  8. SBIR Phase I: Preventing Biofilms on Indwelling Medical Devices with Novel Anti-Biofilm Small Molecules

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project describes a new approach for reducing infections associated with indwelling medical devices. Bacteria on medical devices are particularly ...

    SBIR Phase I 2011 National Science Foundation
  9. Development of Small Molecules to Combat Bacterial Biofilms

    Amount: $545,129.00

    DESCRIPTION (provided by applicant): Bacterial infections are responsible for an estimated 100,000 deaths in the United States each year, and despite the dire unmet medical need, few new treatment op ...

    SBIR Phase I 2011 Department of Health and Human Services
  10. Development of Novel Anti-Biofilm Compounds for Treating Chronic Wounds

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Chronic wounds that fail to respond to traditional therapeutic interventions afflict millions of people each year, and direct costs associated with treatin ...

    STTR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government